| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 1231 | 5′-O-Benzoyl-2,3′-anhydrothymidine (GMP) |
1231.0010: 10 mg per vial
Please inquire for customized filling and bulk quantities.
|
|
Precursor for [18F]FLT
(3′-Deoxy-3′-[18F]fluorothymidine) |
||
| Manufactured according to GMP requirements for APIs for use in clinical trials (ICH Q7 chapter 19) | ||
| Molar Mass: 328.32 | ||
| C17H16N2O5 | ||
| [70838-44-7] | ||
| White solid packaged in dark glass crimp cap vials. | ||
| Purity: > 99 % | ||
|
Certificates:
CoA with NMR and IR spectra (identity); HPLC (purity); GC (residual solvents) |
||
|
Chemical Name: CA index name: 2,5-Methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one, 3-[(benzoyloxy)methyl]-2,3-dihydro-8-methyl-, (2R,3R,5R)- |
||
|
Synonymes: 5′-O-Benzoyl-2,3′-anhydrothymidine; 2,5-Methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one, 3-[(benzoyloxy)methyl]-2,3-dihydro-8-methyl-, (2R,3R,5R)-; (2R,3R,5R)-3-[(benzoyloxy)methyl]-2,3-dihydro-8-methyl-2,5-methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one; BATH |
||
|
Literature: Same as product number 1230. |
||
| date of product catalogue issue: 10 May 2017 | ||